期刊文献+

载microRNA-148b壳聚糖/透明质酸纳米粒制备及鉴定 被引量:5

Preparation and characterization of chitosan/hyaluronic acid nanoparticles for microRNA-148b delivery
下载PDF
导出
摘要 目的:制备并评价壳聚糖/透明质酸(CS/HA)纳米粒负载microRNA-148b(miR-148b)的效果。方法:制备CS/HA/miR-148b纳米粒,用激光纳米测量仪和透射电镜对其粒径、电位和形态进行观察。通过凝胶阻滞实验观察CS/HA纳米粒对miR-148b的包载情况。用CCK-8实验评价CS/HA/miR-148b纳米粒对大鼠骨髓间充质干细胞(MSCs)的细胞毒性;转染实验和流式细胞术检测转染效率。结果:CS/HA/miR·148b纳米粒呈球形,粒径为160~370 nm,电位为+15 mV^+41 mV。氮磷比为20可以达到最佳的包封效果。CS/HA/miR-148b纳米粒对大鼠MSCs无细胞毒性并且具有较高的转染效率。结论:CS/HA纳米粒可以安全有效地将miR-148b转染入MSCs中。 Objective: To prepare and characterize chitosarr/hyaluronic acid (CS/HA) nanoparticles for miRNA-148b(miR-148b) delivery. Methods: CS/HA/miR-148b nanoparticles were prepared. The particle size, zeta potential, morphology were investigated by nano laser granulometer and TEM respectively. The encapsulation efficiency of CS/HA nanoparticles was evaluated by gel retarding analysis. The cytotoxicity and transfection efficiency of CS/HA/miR-148b nanoparticles on rat bone marrow mesenchymal stem cells (MSCs) were evaluated by CCK-8 assay, transfection assay and FCM respectively. Results: The CS/HA/miR-148b nanoparticles were discrete spherical particles with the diameter of 160 to 370 nm and zeta potential of + 15 to +41 mV. N/P ratio at 20:1 of the nanoparticles showed the optimum encapsulation efficiency for miR-148b. CS/HA/miR-148b nanoparticles exhibited no cytotoxicity to MSCs and could deliver miR-148b to the MSCs at high transfection efficiency. Condusion: CS/HA/miR-148b nanoparticles are safe and effective for miR-148b delivery into MSCs.
作者 吴广升 惠光艳 WU Guangsheng HUI Guangyan.(266071, Navy Qingdao First Sanatorium, China)
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2017年第1期31-35,共5页 Journal of Practical Stomatology
基金 青岛市市南区公共领域科技支撑计划项目(编号:2014-14-047-SW)
关键词 微小RNA 壳聚糖 纳米粒 间充质干细胞(MSCs) microRNA Chitosan Nanoparticle Mesenchymal stem cells ( MSCs )
  • 相关文献

参考文献2

二级参考文献19

  • 1邓婧,符大勇,宋文斌,袁昌青.壳聚糖对几种口腔常见致病菌的体外抑制作用[J].上海口腔医学,2005,14(1):74-76. 被引量:21
  • 2Gun CJ,Pan Q,Cheng T,et al. Changes in microRNAs associated withhepatic stellate cell activation status identify signaling pathways [ J ]. FEBS J,2009,276(18) :5163 -5176.
  • 3Jiang X,Tsitsiou E, Herrick SE,et al. MicroRNAs and the regulation of fibrosis[ J ]. FEBS J ,2010,277 (9) :2015 - 2021.
  • 4Wang JJ, Zeng ZW, Xiao RZ,et al. Recent advances of chitosan nanop- articles as drug carriers[J]. Int .1 Nanomedicine,2011,6( 1 ) :765 - 774.
  • 5l~e D, Mohapatra SS. Chitosan nanopartlele - mediated gene transfer [J]. Methods Mol Biol,2008,433( 1 ) :127 - 140.
  • 6Sekiya Y, Ogawa T, Yoshizato K, et al. Suppression of hepatic', stellate cell activation by microRNA- 29b[ J]. Biochem Biophys Res Com- mun,2011,412(1) :74 -79.
  • 7Roderburg C,Urban GW, Bettermann K, et al. MicroRNA profiling re- veals a role for miR -29 in human and murine liver fibrosis[ J ]. Hepa- tology,2011,53( 1 ) :209 -218.
  • 8Ogawa T, lizuka M, Sekiya Y,et al. Suppression of Type I collagen pro- duction by microRNA -29b in cultured human stellate[ J ]. Biochem Biophys Res Commun,2010,391 (1) : 316 -321.
  • 9I,una C, 1,i G, Qiu J ,et al. Cross- talk between miR- 29 and transfor- ming growth factor - betas in trabecular meshwork cells [ J ]. Invest Ophthalmol Vis Sci ,2011,52(6) :3567 -3572.
  • 10You JO, Liu YC, Peng CA. Efficient gene transfectionusing ehitosan- alginate core - shell nanoparticles [ J ]. lnt J Nanomedicine, 2006, 1 (2) :173 - 180.

共引文献4

同被引文献28

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部